Regulation of bronchomotor tone in conscious calves

Ergovaline, an endophytic alkaloid. 2. Intake and impact on animal production, with reference to New Zealand

On the basis of published reports, the daily intake of the alkaloid ergovaline from the consumption of endophyte-containing ryegrass in New Zealand ranges from 0.008 to 0.287 mg ergovaline/kg LW0.75.day. Most of the reports are based on the use of standard endophyte-containing ryegrass and, thus, it is difficult to disassociate the impact of ergovaline consumption from that of lolitrem B. However, physiological effects of ergovaline consumption, such as reduced circulating prolactin concentration, vasoconstriction and elevated core temperature, have been detected at fairly low ergovaline intake, whereas decreased feed intake, liveweight gain and milk production have not generally been observed in animals at an intake below 0.07 mg ergovaline/kg LW0.75.day. Intakes above this value represent only 17% of published values. There are insufficient data to suggest a threshold ergovaline intake associated with heat stress with animal-welfare implications. The relationship between published ergovaline intake and the corresponding ergovaline concentration in pasture is poor (R2 = 0.48), but on average an intake of 0.07 ergovaline/kg LW0.75.day is associated with an ergovaline concentration in ryegrass of 0.70 mg/kg DM. About 16–18% of published ergovaline concentrations in ryegrass pasture exceed this value. The ergovaline concentration in ryegrass is greater in the basal parts of the plant than in the leaf and during the late summer–autumn than in spring. Animals grazing in the lower sward horizons (horizontal grazing plane) are more at risk of high ergovaline intake, although the reduction in grazing intake induced by grazing at low pasture height aids in limiting ergovaline intake. As pasture growth rates decline in late summer, supplementary feed may be used to maintain stocking rate and, if such feeds have zero ergovaline concentration, they serve to dilute the mean dietary ergovaline intake. Ergovaline-containing ryegrass pastures are widely used in New Zealand. It appears that farmers consider the risks of depressed animal production on these pastures to be less than the benefits ergovaline bestows through its deterrent effect of specific insect attack and thus greater survival and pasture persistence.

Measurement of respiratory function by impulse oscillometry in horses

REASONS FOR PERFORMING STUDY

Due to technical implementations and lack of sensitivity, pulmonary function tests are seldom used in clinical practice. Impulse oscillometry (IOS) could represent an alternative method.

OBJECTIVES

To define feasibility, methodology and repeatability of IOS, a forced oscillation technique that measures respiratory resistance (Rrs) and reactance (Xrs) from 5 to 35 Hz during spontaneous breathing, in horses.

METHODS

Using 38 healthy horses, Rrs and Xrs reference values were defined and influence of individual biometrical parameters was investigated. In addition, IOS measurements of 6 horses showing clinical signs of heaves were compared to those of 6 healthy horses.

RESULTS

Airtightness and minimal dead space in the facemask were prerequisites to IOS testing and standardisation of head position was necessary to avoid variations in Rrs due to modified upper airway geometry. In both healthy and diseased animals, measurements were repeatable. In standard-type breeds, the influence of the horse's size on IOS parameters was negligible. An increase in R5Hz greater than 0.10 kPa/l/sec and R5Hz>R10Hz, combined with negative values of Xrs between 5 and 20 Hz, was indicative of heaves crisis.

CONCLUSIONS

IOS is a quick, minimally invasive and informative method for pulmonary function testing in healthy and diseased horses.

POTENTIAL RELEVANCE

IOS is a promising method for routine and/or field respiratory clinical testing in the equine species.

Respiratory mechanics in sedated and nonsedated adult llamas

OBJECTIVE

To validate the use of noninvasive pulmonary function testing in sedated and nonsedated llamas and establish reference range parameters of respiratory mechanical function.

ANIMALS

10 healthy adult llamas.

PROCEDURES

Pulmonary function testing in llamas included the following: measurement of functional residual capacity (FRC) via helium dilution, respiratory inductance plethysmography (RIP) to assess breathing pattern and flow limitations, esophageal-balloon pneumotachography, and a monofrequency forced oscillatory technique (FOT; 1 to 7 Hz) before and after IM administration of xylazine (0.2 mg/kg).

RESULTS

The following mean +/- SD measurements of respiratory function were obtained in nonsedated llamas: FRC (5.60 +/- 1.24 L), tidal volume (1.03 +/- 0.3 L), dynamic compliance (0.83 +/- 0.4 L/cm H(2)O), pulmonary resistance (R(L); 1.42 +/- 0.54 cm H(2)O/L/s), and respiratory system resistance (2.4 +/- 0.9, 2.3 +/- 0.7, 2.2 +/- 0.6, 2.7 +/- 0.7, and 2.5 +/- 0.5 cm H(2)O/L/s at 1, 2, 3, 5, and 7 Hz, respectively) by use of FOT. Measurements of flow limitations via RIP were comparable to other species. Sedation with xylazine induced significant increases in R(L) and maximum change in transpulmonary pressure. Following sedation, a mean 127% increase in R(L) and mean 116% increase in respiratory system resistance were observed across 1 to 7 Hz. The magnitude of change in respiratory system resistance increased with decreasing impulse frequency, suggesting bronchoconstriction.

CONCLUSIONS AND CLINICAL RELEVANCE

Noninvasive pulmonary function testing is well tolerated in untrained unsedated llamas. These techniques have clinical applications in the diagnosis and treatment of respiratory tract disease, although testing should not be performed after sedation with xylazine.

An animal model for ultrasound lung imaging

In the past decade, a number of clinical investigators have used ultrasound (US) to image the lung during video-assisted thoracoscopic surgery (VATS). In contrast, animal studies have shown prohibitively high attenuation levels in the lung, incompatible with the ability to image the lung. We hypothesized that the use of anesthesia during VATS augments lung collapse upon exposure to atmospheric pressure; thus, making US lung imaging possible. To test this hypothesis, we compared the effect of two commonly used anesthetic protocols on our ability to image 200 microL of US gel injected in rabbit lungs using a pulse echo transducer at 13 MHz. The anesthetic protocol, using acepromazine, ketamine and isoflurane, allowed US lung imaging in rabbits. It is concluded that US at 13 MHz can detect 200 microL of US gel injected into the lung parenchyma in a rabbit model.

Drugs affecting the respiratory system

Differences in the disposition of drugs among exotic animals is a well-recognized hurdle when treating disease. Differences exist in pharmacokinetics, pharmacodynamics, and disease processes. This article focuses on the principles of treating respiratory tract diseases, with the recognition that not all drugs are indicated for use in all exotic species. The discussion begins with a description of respiratory physiology as it pertains to response to drugs, using the mammalian lung as a template. The role of respiratory defense mechanisms in airway protection and disease is addressed. Drugs used to treat the respiratory tract include the bronchodilators and anti-inflammatory drugs, drugs that modify respiratory secretions (e.g., mucolytics, mucokinetics, and expectorants), antitussive drugs, and decongestants. Aerosolization is an important adjuvant for respiratory therapy as long as precautions are met. Infectious diseases are among the more common respiratory diseases encountered, and the discussion includes a focus on the use of antibiotics for treating respiratory tract infections.

The effect of xylazine on plasma thromboxane B2 concentration in sheep

alpha 2-adrenoceptor agonist drugs can cause respiratory changes leading to a short period of hypoxaemia in sheep. It has been suggested that this is due to transient platelet aggregation and pulmonary microembolism. If platelet aggregation were to follow platelet activation in response to the administration of alpha 2 agonists, plasma thromboxane levels would be expected to rise. This study was carried out to measure plasma thromboxane B2 concentrations before and after the intravenous administration of the alpha 2-agonist drug xylazine at a dose of 0.1 mg/kg. It was found that the plasma thromboxane concentration rose by 320% and, furthermore, the rise was prevented by the prior administration of atipamezole hydrochloride (0.125 mg/kg), an alpha 2-adrenoceptor antagonist.

The effect of xylazine on the isolated sheep trachea

The effect of xylazine on the isolated sheep trachea and its possible interactions with the alpha 2-adrenergic antagonist, atipamezole, and the anticholinergic agent, atropine, was studied. The mechanical responses of the tracheal preparations were recorded after exposing each one to cumulatively increasing concentrations of xylazine alone or in the presence of atipamezole or atropine. Xylazine exerted a concentration-dependent contractile effect, with a threshold concentration of 10(-7) M while the maximum activity was produced at a concentration of 10(-5) M (EC50 = 2.3 x 10(-7). This xylazine-induced contractile effect was inhibited by atipamezole, but not significantly modified by atropine. Thus, it is concluded that alpha 2-adrenoceptors exist in the sheep trachea and it is suggested that alpha 2-adrenoceptor agonists may act on airways in sheep directly through stimulation of peripheral alpha 2-adrenergic receptors and indirectly via central alpha 2-adrenergic receptor activation of parasympathetic tone.

Increased airway pressure in response to xylazine is inhibited by both atipamezole and atropine in sheep

The effect on airway pressure of xylazine alone or following the administration of atipamezole or atropine was studied in 31 halothane-anaesthetized sheep. Xylazine produced a significant increase in airway pressure which lasted for at least 30 min. This effect was inhibited by both atipamezole and atropine. The results suggest that the xylazine-induced increase in airway pressure in sheep is alpha 2-adrenergically mediated. Moreover, activation of central alpha 2-adrenoceptors leading to vagal stimulation may be involved.

Autonomic innervation of the airways

A review is given of the literature concerning the autonomic innervation of airway smooth muscle. The cholinergic, adrenergic and non-cholinergic non-adrenergic (NANC) systems in humans and several animal species are discussed. The diagnostic and therapeutic possibilities and limitations of new receptor specific agonists and antagonists are also discussed.